NCT03606785View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of Single Dose Tranexamic Acid in Reducing Blood Loss During Colorectal Cancer Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 5, 2018

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Colorectal Surgery
Interventions
DRUG

Tranexamic Acid Injection

The TA group will receive an intravenous bolus of (10 mg/kg) in 100 ml of normal saline over 20 minutes after induction of anesthesia and before surgical incision

DRUG

placebo injection

patients will receive a placebo of 100 mL 0.9% normal saline

Trial Locations (1)

Unknown

NCI, Cairo university, Cairo

All Listed Sponsors
lead

Assiut University

OTHER

NCT03606785 - Evaluation of the Efficacy and Safety of Single Dose Tranexamic Acid in Reducing Blood Loss During Colorectal Cancer Surgery | Biotech Hunter | Biotech Hunter